Norway to carry out fast-track trials of Ebola vaccine

Norway is leading the work to develop the world’s first vaccine against the Ebola virus in Guinea, where the epidemic first broke out. The Ebola epidemic is continuing to spread in West Africa. So far, over 15 000 people have been infected with the virus, and it has had an enormous impact on whole societies.   

Norway has so far provided over NOK 334 million in funding for international efforts to combat Ebola. It is important to ensure that those infected are given treatment, and to support the poorly developed health services in the affected areas. A crucial part of this work focuses on preventing the further spread of the epidemic, and staving off future outbreaks.

‘We have no time to lose. I am therefore pleased that Norway has very quickly made progress with our proposal to test vaccines in Guinea, where the first Ebola outbreak was recorded in December last year. This is part of Norway’s significant engagement in the fight against Ebola. The development of an effective vaccine would perhaps be the single most important step towards stopping the epidemic once and for all and preventing new outbreaks in the future,’ said Minister of Foreign Affairs Børge Brende.

Mr Brende visited West Africa in October, and saw for himself the massive need for additional health workers, clinics and equipment, as well as for leadership and coordination of the efforts in the formerly conflict-affected countries.

Trials of Ebola vaccines involve a high level of risk, and they need to be conducted in several locations in order to have a reasonable chance of success. While the US has been leading the work to test vaccines in Liberia and Sierra Leone, this work has not yet begun in Guinea.

‘In October, following an enquiry from the World Health Organization, Norway took on responsibility to test vaccines in Guinea. This will be an important contribution to the fight to stop the spread of Ebola. We hope that we will soon have an effective vaccine available for this extremely serious disease,’ said Minister of Health and Care Services Bent Høie.

The World Health Organization and Norway gathered the world’s leading experts on vaccine trials for a planning meeting in November. In less than a month, the Ministry of Foreign Affairs and the Ministry of Health and Care Services have led the work on the project from developing the concept, to financing, to technical approval. Detailed planning of the trials is now under way, and the aim is to begin the trials in Guinea in early 2015.  

Norway has allocated almost NOK 23 million to vaccine development through the Research Council of Norway’s Programme for Global Health and Vaccination Research (GLOBVAC). The project is run by the Norwegian Institute of Public Health

 

Related news

Latest news

USCG confirms OPtimarin in Line for Ballast Water Approval

The United States Coast Guard (USCG) has confirmed that Norwegian ballast water treatment specialist Optimarin has become the first supplier to submit an application for type approval.

New order for Servogear

Servogear announces that they have received a new order from Brødrene Aa. 

Norwater AS reports boost in sales

The Norwater team reports of great interest and busy days in 2016. In a press release, they state that as of the first 8 months of the year, 2016 sales are already beyond target for the year as a whole.

Gaia-facts reaching ground control

The European Space Agency (ESA) has released the first data from the Gaia mission, which has the tremendous task of building the most precise 3D map of the Milky Way.

Polish delegation for Norwegian circular waste management

Against the background of the EU's ambitious waste management targets, Norwegian and Polish stakeholders met on Wednesday 14 September in Drammen.

Milestone at Mongstad Water Treatment Plant

SAR AS reports that an extensive upgrade to the water treatment plant at Mongstad reached a new milestone July. 

Servogear signs new contract with Özata Shipyard

Servogear has announced the signing of a new contract with Özata Shipyard in Turkey. The contract includes the delivery of Servogear Ecoflow PropulsorTMfor two 39 meter passenger catamarans (YN 41 & YN 42).

Statoil and Petrobras strengthen strategic partnership

Statoil reports that they have strengthened their cooperation in Brazil by signing a Memorandum of Understanding (MoU) with Petrobras.

TechInvent and Island Offshore/Centrica announced winners of ONS Innovation Award

TechInvent and Island Offshore/Centrica were announced winners of the ONS 2016 Innovation Awards, at the Innovation Awards Ceremony Tuesday 30 August.